Puma Biotechnology (PBYI) Gross Margin (2017 - 2026)
Puma Biotechnology's Gross Margin was 77.92% in Q2 2026, up 1.38 percentage points from 76.54% a year earlier and up 1.18 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Gross Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Puma Biotechnology's Gross Margin was 74.83% through Jun 30, 2026, up 2.50 percentage points year-over-year; for FY2025, it was 74.53%, up 2.48 percentage points from FY2024.
- Gross Margin shows a five-year change of -7.98 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 72.06% in FY2024 (-1.34 pp), 73.40% in FY2023 (-2.44 pp), 75.84% in FY2022 (+1.00 pp) and 74.84% in FY2021 (-7.67 pp).
- The Q2 2026 figure marks the highest quarterly Gross Margin since Q2 2023.
- Compared with a year earlier, Gross Margin was higher in four of the last eight quarters, with an average year-over-year change of +0.77 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q3 2025 (a gain of 13.78 percentage points); the worst was Q3 2024 (a drop of 12.45 percentage points).
- Per Business Quant data, PBYI's Gross Margin in the three quarters before Q2 2026 was 76.74% (Q1 2026), 69.35% (Q4 2025) and 77.65% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 72.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 72.40% |
| Jun 30, 2026 | 77.92% |
| Mar 31, 2026 | 76.74% |
| Dec 31, 2025 | 145.15% |
| Sep 30, 2025 | 77.65% |
| Jun 30, 2025 | 76.54% |
| Mar 31, 2025 | 77.06% |
| Dec 31, 2024 | 76.44% |
| Sep 30, 2024 | 63.87% |
| Jun 30, 2024 | 77.36% |
| Mar 31, 2024 | 75.49% |
| Dec 31, 2023 | 66.30% |
| Sep 30, 2023 | 76.33% |
| Jun 30, 2023 | 78.27% |
| Mar 31, 2023 | 74.95% |
| Dec 31, 2022 | 74.36% |
| Sep 30, 2022 | 78.12% |
| Jun 30, 2022 | 74.94% |
| Mar 31, 2022 | 76.29% |
| Dec 31, 2021 | 78.51% |
API Access
Puma Biotechnology Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();